###preview_mode_button### ###cta###

FACULTY LIST
(alphabetical order)

 

Inhye E. Ahn, MD Lymphoid Malignancies Section, National Heart, Lung, and Blood Institute, Bethesda, United States

Othman Al-Sawaf, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Iona Ashworth, PhD Department of Haematology, Brighton and Sussex University Hospital Trust, Brighton, United Kingdom

Francesc Bosch, MD, PhD Department of Haematology, University Hospital Vall d'Hebron, Autonomous University, Barcelona, Spain

Jennifer Brown, MD, PhD Department of Medical Oncology, Dana Farber Cancer Institute, Boston, United States

Chiara Cassarino, Laboratorio de Inmunología Oncológica, Instituto de Medicina Experimental (IMEX)-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)- Academia Nacional de Medicina (ANM), Buenos Aires, Argentina

Marta Coscia, MD, PhD Department of Hematology, University of Turin, Turin, Italy

Paula Cramer, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Alexey V. Danilov, MD, PhD City of Hope National Medical Center, Duarte, United States

Matthew S. Davids, MD Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States

Thi Huong Lan Do, Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland

Barbara Eichhorst, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Lesley Fallowfield, MD, Department of Oncology, University College London Medical School, London, United Kingdome

Kirsten Fischer, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Paolo Ghia, MD University Vita-Salute San Raffaele, Milano, Italy

Romaine Guièze, MD CHU Clermont Ferrand, Clermont Ferrand, France

Michael Hallek, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Paul J. Hampel, MD Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, United States

Carmen Herling, MD Clinic and Polyclinic for Hematology, Cell Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany

Henriette Huber, MD Karlsruhe Municipal Hospital, Karlsruhe, Germany

Nathalie Javidi-Sharifi, MD, PhD Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States

Arnon P. Kater, MD, PhD Lymphoma and Myeloma Center, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, Netherlands

Emma Kennedy, PhD Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom

Thomas J. Kipps, MD, PhD University of California, Department of Medicine, Moores Cancer Center, San Diego, California, United States

Binyamin A. Knisbacher, MD, PhD Cancer Research Center, Sheba Medical Center, Tel Hashomer, Israel

Viktoria Kohlhas, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Nadine Kutsch, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Stephen Martindale, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States

Kiyomi Mashima, MD, PhD Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States

Riccardo Moia, MD Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy

Talha Munir, MD Department of Haematology, St. James's University Hospital, Leeds, United Kingdome

Ferran Nadeu, MD Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Sameer A. Parikh, MD Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, United States

Matthias Ritgen, MD Department of Medicine II, University of Schleswig-Holstein, Kiel, Germany

Pauline Robbe, PhD Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, United Kingdome

Ilaria Romano, MD, PhD Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland

Richard Rosenquist Brandell, MD, PhD Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Davide Rossi, MD, PhD Hospital San Giovanni, Bellinzona, Switzerland

Neil Ruthen, Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, United States

Lydia Scarfó, MD Strategic Research Program on Chronic Lymphocytic Leukemia, IRCCS Ospedale San Raffaele, Milano, Italy; Università Vita Salute San Raffaele, Milano, Italy

Florian Simon, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Philipp B. Staber, MD, PhD Department of Hematology and Hemostosiology, University Hospital Vienna, Austria

Deborah M. Stephens, MD Internal Medicine/Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, United States

Stefan Stilgenbauer, MD Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany

Eugen Tausch, MD Division of CLL, Department of Internal Medicine III, University of Ulm, Ulm, Germany

Philip A. Thompson, MD, Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia

Patrick D. Thornton, MD Department of Haematology, Beaumont Hospital, Dublin, Ireland

Martin Trepel, MD Department of Hematology and Medical Oncology, Augsburg University Hospital, Augsburg, Germany

Julia von Tresckow, MD Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Clemens M. Wendtner, MD Hematology and Internal Oncology, Interdisciplinary Oncology Center (IOZ), Munich, Germany

Alexander F. Vom Stein, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Jennifer A. Woyach, MD The Ohio State University Comprehensive Cancer Center, Columbus, Columbus, United States

Loic Ysebeart, MD, PhD Institut Universitaire du Cancer-Toulouse Oncopole, Haematology Department, Toulouse, France